As shown in Figure 2Bii, treatment with TRAIL/Apo2L (25 ng/ml) alone reduced number of colonies whereas exposing colon carcinoma cells to TS and TRAIL in combination synergistically decreased the number of cancer cell colonies. The gene discussed is TNFSF10; the disease is colon carcinoma.